Differential sensitivity of human prostatic cancer cell lines to the effects of protein kinase and phosphatase inhibitors
✍ Scribed by Oskar W. Rokhlin; Michael B. Cohen
- Book ID
- 117468220
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 547 KB
- Volume
- 98
- Category
- Article
- ISSN
- 0304-3835
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Our results revealed that the blockade of epidermal growth factor receptor (EGFR) tyrosine kinase and protein kinase A (PKA) signaling pathways by specific inhibitors (PD153035 and Rp‐cAMPs) leads to a synergistic inhibition of EGF‐ and serum‐stimulated growth of human prostatic cancer
## Abstract Recently, we identified a nucleoside analog named ARC (4‐amino‐6‐hydrazino‐7‐β‐D‐ribofuranosyl‐7H‐Pyrrolo[2,3‐d]pyrimidine‐5‐carboxamide), which has the properties of a general transcriptional inhibitor. Here, we report the characterization of ARC on a panel of colorectal cancer (CRC) c
The stimulated secretion of prostatic acid phosphatase (PAcP) has been known to be a hallmark of androgen action on human prostate epithelial cells for the last five decades. The molecular mechanism of androgen action on PAcP secretion, however, has remained mostly unknown. We investigated the molec